Just Earth News | @justearthnews | 06 Oct 2020, 06:05 am Print
Pixabay
Moscow/Sputnik: Russia has shared with the World Health Organization (WHO) the data obtained during phase I and II of the clinical trials of its Sputnik V vaccine against COVID-19, an adviser at the WHO's Western Pacific Regional Office said on Tuesday.
"On the Russian vaccine again, this is an update from the last briefing. During that time, it was a very early stage of discussion between WHO and the regulatory authority of Russia, and now we know that Russia has already shared their data for the phase I and phase II clinical trial to WHO, and the Russian national regulatory authority itself has already given a conditional approval for the vaccine. Beyond that, we do not have information yet as to the deployment of this vaccines into other countries," Dr. Socorro Escalante said at a briefing.
- Over 260 million people in USA will be either obese or overweight by 2050, reveals new study
- New report shows unhealthy eating drives $8 trillion in annual hidden costs
- WHO lists 17 pathogens as top priorities for developing new vaccine
- Study finds low-sugar diet in early childhood has a connection with reducing diabetes and BP risk
- Low-sugar diet in early childhood reduces lifetime risk of chronic disease, shows new study
